Blood Podcast – Season 2, Episode 47 | Blood | American Society of Hematology Asciminib versus bosutinib in CML; dopamine signaling and hematopoietic stem cells; complement factor C5 and VTE risk In this week’s episode, we’ll learn more about the efficacy of asciminib in patients with chronic myeloid leukemia who are resistant or intolerant to two or more tyrosine kinase inhibitors,…
In this issue of Blood, Vadivel et al showed that Staphylococcus aureus promotes therapeutic resistance to several drugs commonly used in the treatment of
In this issue of Blood, Yang et al provide insight into the biological mechanisms underlying gestational thrombocytopenia (GT).1 Using sequencing data from
In this issue of Blood, Vadivel et al showed that Staphylococcus aureus promotes therapeutic resistance to several drugs commonly used in the treatment of
Introduced by Associate Editor Thomas Ortel, this Review Series focuses on factor XI (FXI). The series opens with a review of the biology of FXI,…
Human hematopoietic stem cells can be corrected to restore endogenous RAG2 gene expression while preserving durable engraftment potential.Gene-corrected RA
In this issue of Blood, Donkó et al report the clinical and biological features of a unique cohort of 54 patients from 37 families with Ras-related C3…
In this issue of Blood, Yang et al provide insight into the biological mechanisms underlying gestational thrombocytopenia (GT).1 Using sequencing data from
In this issue of Blood, Vadivel et al showed that Staphylococcus aureus promotes therapeutic resistance to several drugs commonly used in the treatment of
TP53 mutations are associated with distinct clinicopathological and prognostic features which warrants a separate entity apart from AML-MR.AML with myelody
In this issue of Blood, Donkó et al report the clinical and biological features of a unique cohort of 54 patients from 37 families with Ras-related C3…
